CClinicalTrials.gg
CompletedNCT05734573Updated Feb 21, 2023

The Effectiveness of Eating Disorder Treatment

An interventional study of Family-based treatment in Eating Disorders, sponsored by Helsinki University Central Hospital. Completed. Open to female participants aged 13 Years to 18 Years. Per ClinicalTrials.gov, last updated 2023-02-21.

Sponsored by Helsinki University Central Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 9 years 7 months after the study started (first participant enrolled Jun 2013, registered Jan 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
52
Allocation
Not applicable
Ages
13 Years to 18 Years
Sex
Female
01

Study summary

Family-based treatment (FBT), a form of family therapy for eating disorders (ED) in young patients, has proven to be effective in numerous large-scale studies. This study aims to evaluate outcomes of the treatment for anorexia nervosa (AN) in a 'real-world' setting in a specialized outpatient clinic in Helsinki, Finland. Fifty-two young female patients seen for treatment between June 2013 and December 2017 were included in the study. Demographic and treatment characteristics, weight, and ED symptoms before and after treatment are reported

Read the detailed description

Aim: The naturalistic outcome of outpatient FBT for adolescent AN was investigated.

Methods: Fifty-two female patients and their families who received FBT at a tertiary eating disorders unit participated in the study. Data on their pre-treatment parameters, treatment details, and condition at the end of treatment (EOT) was collected from their medical records

02

Conditions studied

  • Eating Disorders
03

In context

Feeding and Eating Disorders

740 studies on the registry are indexed under Feeding and Eating Disorders; 159 are open to participants now.

This study's enrollment of 52 is below the median of 75 across 540 interventional studies indexed under Feeding and Eating Disorders.

Browse Feeding and Eating Disorders studies →

Lead sponsor

Helsinki University Central Hospital is the lead sponsor of 299 studies on the registry; 60 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years to 18 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Clinical diagnosis of Anorexia nervosa
  • Admitted to FBT at the Eating Disorder Unit from June 1, 2013, through December 31, 2017

Exclusion criteria

Exclusion Criteria:

  • No exclusions
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
52 participants (actual)

Interventions

  • BehavioralFamily-based treatment

    FBT is carried out by a family therapist who has received FBT training. The duration of FBT is commonly 6-12 months, in most cases comprising 10-20 sessions. At the beginning of treatment, there are weekly sessions; later in treatment, the sessions are less frequent. The patient and their family meet their psychiatrist every four to six weeks, and the family therapist also takes part in these meetings. The treatment is implemented in accordance with the FBT treatment manual.

06

What researchers measure

Primary outcomes

  1. % of patients with body weight normalization in treatment

    Rate of patients with a normal body weight defined as a BMI over 18.5 at the end of treatment was calculated.

    Time frame: Treatment period, aprox. 1 year

  2. % of patients with eating disorder symptoms at the end of treatment

    The data of any eating disorder symptoms detected by a psychiatrist at the end of treatment were collected from the medical records, and the incidence was calculated.

    Time frame: Treatment period, aprox. 1 year

  3. % of patients in need for a further treatment after the intervention

    Rate of patients who still needed treatment after the FBT intervention from was assessed at the end of treatment. The data were obtained from the medical files of the patients.

    Time frame: Treatment period, aprox. 1 year

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Jones M, Volker U, Lock J, Taylor CB, Jacobi C. Family-based early intervention for anorexia nervosa. Eur Eat Disord Rev. 2012 May;20(3):e137-43. doi: 10.1002/erv.2167. Epub 2012 Mar 22. PubMed 22438094 ↗
  • Lock J. Family therapy for eating disorders in youth: current confusions, advances, and new directions. Curr Opin Psychiatry. 2018 Nov;31(6):431-435. doi: 10.1097/YCO.0000000000000451. PubMed 30063479 ↗
  • Lock J, Le Grange D. Family-based treatment: Where are we and where should we be going to improve recovery in child and adolescent eating disorders. Int J Eat Disord. 2019 Apr;52(4):481-487. doi: 10.1002/eat.22980. Epub 2018 Dec 6. PubMed 30520532 ↗

Study documents

  • Protocol and statistical analysis plan · Jan 21, 2023

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No — The dataset generated for the study is not publicly available due to privacy restrictions. The data are available on request from the principal investigator

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 21, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05734573
Lead sponsor
Helsinki University Central Hospital
Responsible party
Svetlana Oshukova (Doctor of medicine, Helsinki University Central Hospital) — Principal investigator
First posted
Feb 21, 2023
Start date
Jun 1, 2013
Primary completion
Dec 31, 2017
Completion
Dec 31, 2022
Last update
Feb 21, 2023

Study contacts

Jaana Suokas, Dos
study director · Helsinki University Central Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion